Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04107181 · ClinicalTrials.gov registry record · NA

Pilot Study for Speculum Free Cervical Cancer Screening

A NA study of Cervical Cancer, sponsored by Duke University.

Recruiting
Registry status
NA
Development phase
305
Enrollment target
1
Study location

NCT04107181 is a NA study of Cervical Cancer that is actively recruiting participants, run by Duke University. The registered enrollment target is 305 participants, below the 568-participant average among 144 other Cervical Cancer trials with a reported enrollment target (46% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04107181, a NA study of Cervical Cancer, is actively recruiting participants, sponsored by Duke University.

RECRUITING
Registry status
NA
Development phase
305 participants
Enrollment target
1
Study location

Study Summary

The objective of the work described in this protocol is to determine the optical signatures of cervical dysplasia using optical technologies.

Conditions Studied

Interventions

  • DEVICE Introducer "calla" device
  • BEHAVIORAL Interviews only

Study Locations (1)

North Carolina

  • Duke University - Durham

Trial Details

FieldValue
Enrollment Target 305 participants
Start Date 2016-04-14
Est. Completion 2028-02-01
Phase NA

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT04107181

The ClinicalTrials.gov registry entry for NCT04107181 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 305 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 568-participant average among 144 other Cervical Cancer trials with a reported enrollment target (46% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cervical Cancer appearing as the primary indexed condition, and to 2 interventions - of which Introducer "calla" device is the first listed.

NCT04107181 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT04107181 about?

NCT04107181 is a clinical study titled "Pilot Study for Speculum Free Cervical Cancer Screening". The objective of the work described in this protocol is to determine the optical signatures of cervical dysplasia using optical technologies.

What is the current status of trial NCT04107181?

This trial is currently recruiting. It is a NA study. The enrollment target is 305 participants. The study started on 2016-04-14. Estimated completion is 2028-02-01.

What conditions does trial NCT04107181 study?

This clinical trial studies the following conditions: Cervical Cancer.

What interventions are being tested in trial NCT04107181?

The interventions under investigation include: Introducer "calla" device (DEVICE), Interviews only (BEHAVIORAL).

Who is sponsoring clinical trial NCT04107181?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04107181 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cervical Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.